Methods and compositions for reducing autofluorescence
US-2024209423-A1 · Jun 27, 2024 · US
US9759726B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9759726-B2 |
| Application number | US-201514698660-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 28, 2015 |
| Priority date | Mar 27, 2014 |
| Publication date | Sep 12, 2017 |
| Grant date | Sep 12, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are azido-BODIPY compounds of formula (I), cyclooctyne-based fluorogenic probes of formula (IV), and activity-based probes of formula (VI). These compounds undergo azide-alkyne cycloadditions (AAC) with to form triazolyl products. The provided compounds are useful for detection and imaging of alkyne-, or azide-containing molecules. Methods for detection and imaging biomolecules using compounds of the present disclosure are disclosed.
Opening claim text (preview).
We claim: 1. A compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein: B is boron; each instance of G 1 , G 2 ,G 3 , G 5 , G 6 , G 7 and G 8 is independently hydrogen, optionally substituted C 1-6 alkyl, optionally substituted C 1-6 alkenyl, optionally substituted C 1-6 alkynyl, optionally substituted aryl, optionally substituted acyl, —OR A , —CH 2 OR A , —OC(O)R A , —SR A , —N(R B ) 2 , —N(R A )C(O)R A , —C(O)N(R B ) 2 , —CN, —NO 2 , —C(O)R A , —C(O)OR A , —S(O)R A , —SO 2 R A , —SO 3 R A , —SO 2 N(R B ) 2 , and —NHSO 2 R B ; each R A is independently selected from hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted heterocyclyl, and optionally substituted aryl; each R B is independently selected from hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted heterocyclyl, and optionally substituted aryl, or two R B taken together with the intervening nitrogen form a heterocycle; each instance of G 4a and G 4b is fluoro, alkyl, alkoxy, aryloxy, or alkynyl; wherein alkyl and alkoxy groups are unbranched, saturated, and have 1-4 carbon atoms; aryl groups and aryl groups of aryloxy can be either carbocyclic aryl or heterocyclic aryl; carbocyclic aryl groups have a total of 6-20 carbon atoms, including carbon atoms of substituents; heterocyclic aryl groups have a total of 5-20 carbon atoms, including carbon atoms of substituents; carboalkoxy groups are alkyl esters of a carboxylic acid wherein alkyl groups are as defined above; each alkyl, aryl, alkoxy, aryloxy, benzo, and carboalkoxy, independently, may be unsubstituted or substituted with one or more substituent; alkyl substituents are halo, hydroxyl, amino, or aryl; aryl substituents are halo, hydroxyl, amino, alkyl, aryl, nitro, or carboxyl; and halo substituents are fluoro or chloro; and n is 0, 1, 2, 3, or 4. 2. The compound of claim 1 , wherein G 1 and G 3 are methyl. 3. The compound of claim 1 , wherein G 5 and G 7 are methyl. 4. The compound of any one of claims 1 - 3 , wherein the compound is of Formula (II): or a pharmaceutically acceptable salt, solvate, or hydrate thereof. 5. The compound of claim 4 , wherein the compound is described by a formula selected from Table 1. 6. The compound of claim 4 , wherein the compound is selected from the group consisting of: 7. A method for imaging an alkyne-containing molecule comprising (a) contacting a compound of claim 1 with a sample containing the alkyne-containing molecule under conditions for ligation of the compound to an alkyne group of the molecule to form a triazole product; and (b) measuring a fluorescent signal released from the triazole product. 8. The method of claim 7 , wherein the contacting step is carried out in the presence of a metal catalyst. 9. The method of claim 8 , wherein the metal catalyst is copper(I). 10. The method of claim 7 , wherein the compound is covalently linked to the alkyne group. 11. The method of claim 7 , wherein the sample contains cells and the alkyne-containing molecule is located on the cell surface or inside the cells. 12. The method of claim 7 , wherein the compound is described by a formula selected from Table 1. 13. The method of claim 7 , wherein the compound is selected from a compound according to claim 6 . 14. The method of any one of claims 7 - 11 , wherein the alkyne-containing molecule is a biomolecule. 15. The method of claim 14 , wherein the biomolecule is a DNA, RNA, protein or glycan. 16. The method of claim 14 , wherein the biomolecule is located on or near the surface of a cell. 17. The method of claim 14 , wherein the biomolecule is an intracellular biomolecule. 18. A method for detecting an alkyne-containing molecule in a sample, comprising: (a) contacting the compound of claim 1 with a sample suspected of having an alkyne-containing molecule; (b) measuring the level of a fluorescent signal released from the sample mixture, and (c) determining the presence of the alkyne-containing molecule in the sample, wherein an enhanced fluorescent signal as compared to a level of the fluorescent signal in the absence of the molecule indicates presence of the alkyne-containing molecule. 19. The method of claim 18 , wherein the contacting step is carried out in the presence of a metal catalyst. 20. The method of claim 19 , wherein the metal catalyst is copper(I). 21. The method of any one of claims 18 - 20 , wherein the sample contains cells and the alkyne-containing molecule is located on or near the surface of a cell or inside a cell. 22. The method of claim 18 , wherein the compound is described by a formula selected from Table 1. 23. The method of claim 18 , wherein the compound is selected from a compound according to claim 6 . 24. The method of claim 18 , wherein the alkyne-containing molecule is a biomolecule. 25. The method of claim 24 , wherein the biomolecule is a DNA, RNA, protein or glycan. 26. The method of claim 24 , wherein the biomolecule is located on or near the surface of a cell. 27. The method of claim 24 , wherein the biomolecule is an intracellular biomolecule. 28. The method of claim 7 or 18 wherein the method comprises the use of the compound for dual fluorescence imaging in a cell.
Nitrogen atoms not forming part of a nitro radical · CPC title
ortho- or peri-condensed with carbocyclic rings or ring systems · CPC title
Electrochemically active labels · CPC title
with fluorescent label · CPC title
Organoboranes and organoborohydrides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.